Cancer News and Research

Latest Cancer News and Research

New review elucidates current treatment approaches for myelodysplastic syndromes

Physician scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have published a review in the Journal of the American Medical Association that clarifies current treatment approaches for myelodysplastic syndromes (MDS), which are rare and often deadly bone marrow cancers.

1 Nov 2022

UT Southwestern study uncovers a causative signaling pathway in breast cancer

UT Southwestern researchers have identified a causative signaling pathway in breast cancer, providing potential new targets for treatment of the most common type of cancer in women.

1 Nov 2022

First preclinical model to study the pathobiology of appendiceal cancer

Appendiceal cancer (malignancies of the appendix, a small tissue pouch that is part of the gastrointestinal tract) is very rare, occurring in perhaps one or two people per 1 million per year.

1 Nov 2022

Pitt researchers receive $792,000 to understand the biology behind ovarian cancer metastasis

Most women diagnosed with metastatic ovarian cancer have a less than five year survival rate. Researchers at the University of Pittsburgh Swanson School of Engineering are working to change that.

1 Nov 2022

Protein kinase CK2 controls CD8+ T cell effector and memory functions during Listeria infection

The protein kinase CK2 is involved in a wide range of biological processes and cellular functions, including inflammatory responses and pathologies associated with inflammation.

1 Nov 2022

Researchers find the root of immunosuppression and chemoresistance in TNBC tumors

Triple-negative breast cancer (TNBC) tumors gain immunosuppression and chemoresistance through interactions between interleukin 34 and myeloid-derived suppressor cells, researchers find.

1 Nov 2022

Pancreatic cancer could be detected up to three years earlier than current diagnoses

Pancreatic cancer could be identified in patients up to three years earlier than current diagnoses, new research suggests.

1 Nov 2022

What is the dose-response association of device-measured vigorous physical activity with mortality and incident cardiovascular disease and cancer?

Researchers demonstrated the benefits of moderate amounts of vigorous physical activity (VPA) completed in short bouts in reducing the risk of heart diseases and cancers.

1 Nov 2022

Novel computational method maps the architecture of human tissues in unprecedented detail

Weill Cornell Medicine researchers have developed a computational method to map the architecture of human tissues in unprecedented detail. Their approach promises to accelerate studies on organ-scale cellular interactions and could enable powerful new diagnostic strategies for a wide range of diseases.

1 Nov 2022

Researchers take a cue from viruses to make glioblastoma more vulnerable to treatment

In the tough war against glioblastoma, scientists are taking a cue from viruses on how to make the aggressive cancer more vulnerable to treatment.

1 Nov 2022

Experts emphasize the need to understand the strengths and limitations of ctHPV DNA testing

Oropharynx cancers caused by human papillomavirus (HPV) have risen dramatically over the years, superseding tobacco use and heavy drinking as the primary driver of new cases. Fortunately, HPV-positive oropharynx cancers have an improved survival rate compared to other head and neck cancers, allowing for less intensive treatment options, especially if diagnosed at early stages.

1 Nov 2022

New nanovaccine greatly improves cytokine production

Cancer immunotherapies, such as immune checkpoint inhibition therapy, have been attracting attention in recent years as new methods for treating cancer. However, immune checkpoint inhibition therapy is only effective in 20%–30% of cancer patients, so developing better drug delivery systems to induce anticancer cellular immunity is necessary.

1 Nov 2022

Researchers develop special molecules that stimulate the immune system

Surgery, radiation, and chemotherapy are the three main therapies used to treat cancerous tumors. The doctoral research network 'Magicbullet::Reloaded'is investigating another approach, with 15 doctoral researchers developing special molecules that stimulate the immune system to destroy tumor cells. In a video, network members explain how doctoral researchers gain valuable experience and research opportunities as part of the network.

1 Nov 2022

BCRF renews funding to support the development of novel therapeutics for triple-negative breast cancer

The Breast Cancer Research Foundation (BCRF) has renewed its funding to Elisa Port, MD, and Hanna Irie, MD, PhD, to study new therapeutic approaches that target aggressive triple-negative breast cancer.

31 Oct 2022

Study expands breast cancer patient population that can benefit from PARP inhibitors

A drug approved to treat breast cancer patients with mutations in the BRCA1 or BRCA2 genes may also benefit people who have other genetic mutations.

31 Oct 2022

IHV researchers receive $7.5 million to control cancer among people living with HIV in sub-Saharan Africa

Institute of Human Virology researchers at the University of Maryland School of Medicine (UMSOM) have received two five-year awards from the National Institutes of Health's National Cancer Institute (NCI) for a total of $7.5 million.

31 Oct 2022

Breastfeeding support extends breastfeeding duration and exclusivity

Researchers determine the impact of different support on the duration and exclusivity of mothers breastfeeding healthy term babies.

31 Oct 2022

Polygenic hazard score could be effective for predicting genetic risk of lethal prostate cancer

Tapping into the Million Veteran Program, an ongoing national research effort to learn how genes, lifestyle and military exposures affect the health of participants, researchers at University of California San Diego School of Medicine and the VA San Diego Healthcare System, with colleagues elsewhere, report that a polygenic hazard score based on 290 genetic variants could be an effective tool for predicting genetic risk of lethal prostate cancer.

31 Oct 2022

New system to detect cancer-related markers on CTCs

Having biopsies taken and endless tests run is nobody's idea of a good time, even if it's necessary for monitoring your health.

31 Oct 2022

Artificial intelligence-based method may help predict early-stage melanoma recurrence

Most deaths from melanoma - the most lethal form of skin cancer - occur in patients who were initially diagnosed with early-stage melanoma and then later experienced a recurrence that is typically not detected until it has spread or metastasized.

31 Oct 2022

Cancer News and Research

Latest Cancer News and Research

New review elucidates current treatment approaches for myelodysplastic syndromes

UT Southwestern study uncovers a causative signaling pathway in breast cancer

First preclinical model to study the pathobiology of appendiceal cancer

Pitt researchers receive $792,000 to understand the biology behind ovarian cancer metastasis

Protein kinase CK2 controls CD8+ T cell effector and memory functions during Listeria infection

Researchers find the root of immunosuppression and chemoresistance in TNBC tumors

Pancreatic cancer could be detected up to three years earlier than current diagnoses

What is the dose-response association of device-measured vigorous physical activity with mortality and incident cardiovascular disease and cancer?

Novel computational method maps the architecture of human tissues in unprecedented detail

Researchers take a cue from viruses to make glioblastoma more vulnerable to treatment

Experts emphasize the need to understand the strengths and limitations of ctHPV DNA testing

New nanovaccine greatly improves cytokine production

Researchers develop special molecules that stimulate the immune system

BCRF renews funding to support the development of novel therapeutics for triple-negative breast cancer

Study expands breast cancer patient population that can benefit from PARP inhibitors

IHV researchers receive $7.5 million to control cancer among people living with HIV in sub-Saharan Africa

Breastfeeding support extends breastfeeding duration and exclusivity

Polygenic hazard score could be effective for predicting genetic risk of lethal prostate cancer

New system to detect cancer-related markers on CTCs

Artificial intelligence-based method may help predict early-stage melanoma recurrence

Understanding the DNA Damage Response in Innate Immunity eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in